Latest News

Lytix Biopharma announces positive Phase I data for LTX-315

Lytix Biopharma decides to initiate a process of raising capital

Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway for a class of new drug candidates - and forms a strategic partnership with the US-based Aurelius Biotherapeutics

Lytix Biopharma has appointed Gry Stensrud as Chief Technology Officer